Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 31
MDL Judge Dismisses Plaintiffs for 'Egregious' Failure to Prosecute
Study Finds Arcoxia Cardiovascular Risks Similar to Older Painkiller
Arthritis Drugs - Issue: 30
COX-2 Inhibitor Prexige Gains EU, Canadian Approval for Osteoarthritis
Man Claims Centocor Concealed Remicade Cancer Risk to Maintain Profits
Calif. Plaintiff Has No Basis for New Vioxx Trial, Merck Says
Merck Says Premature Repatriation of Vioxx Cases Counterproductive
Vioxx Plaintiff Moves for $10 Million Remittitur in lieu of New Trial
Pfizer: Deposing Sales Reps Will Move Bextra/Celebrex Litigation Sideways
